Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07852130Phase 1Completed
Phase 1, randomised trial of modafinil, Oxiracetam, pramiracetam, Nanotropil Novo and aniracetam in sleep deprivation (6 arms). Primary endpoint: Response initiation latency measured by psychologist-coded stimulus-to-committed-response interval at month 6. Started Mar 2026; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07852130.